Ga-68-PSMA-11 in High-risk Prostate Cancer
Condition(s):High-risk Prostate Cancer; Prostate Cancer; Prostate Cancer Metastatic; Lymphnode MetastasisLast Updated:July 27, 2020Completed
Hide Studies Not Open or Pending
Condition(s):High-risk Prostate Cancer; Prostate Cancer; Prostate Cancer Metastatic; Lymphnode MetastasisLast Updated:July 27, 2020Completed
Condition(s):Metastatic Prostate CancerLast Updated:April 3, 2020Completed
Condition(s):Prostatic NeoplasmsLast Updated:March 26, 2021Active, not recruiting
Condition(s):Metastatic Castration-resistant Prostate CancerLast Updated:February 17, 2021Active, not recruiting
Condition(s):Metastatic Hormone Sensitive Prostate CancerLast Updated:March 30, 2021Active, not recruiting
Condition(s):Metastatic Castration-resistant Prostate Cancer; Androgen Resistant Prostatic CancerLast Updated:April 14, 2021Not yet recruiting
Condition(s):Metastatic Castrate Resistant Prostate CancerLast Updated:November 22, 2019Terminated
Condition(s):Metastatic Castration-Resistant Prostate CancerLast Updated:November 15, 2018Completed
Condition(s):Metastatic Castration-Resistant Prostatic CancerLast Updated:September 16, 2020Recruiting
Condition(s):Adenocarcinoma of the Prostate; Bone Metastases; Soft Tissue Metastases; Stage IIA Prostate Cancer; Stage IIB Prostate Cancer; Stage III Prostate Cancer; Stage IV Prostate CancerLast Updated:December 3, 2018Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.